Docosahexaenoic acid acts as QT-shortening agent with genotype-specific beneficial effects in transgenic LQT1, LQT2, LQT5 and LQT2-5 rabbit models
Event:
ESC Congress 2018
Topic:
Drug Treatment of Ventricular Arrhythmias
Session:
Best Posters in ventricular arrythmias and SCD